DAX19.970 -1,4%ESt504.879 -1,6%Top 10 Crypto15,09 -7,4%Dow42.342 ±0,0%Nas19.373 -0,1%Bitcoin92.966 -1,5%Euro1,0369 ±0,0%Öl72,67 ±0,0%Gold2.604 +0,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T NVIDIA 918422 Rheinmetall 703000 Amazon 906866 Palantir A2QA4J MicroStrategy 722713 Bayer BAY001 Micron Technology 869020 Volkswagen (VW) vz. 766403 Siemens Energy ENER6Y Atos 877757 Apple 865985 Commerzbank CBK100 Mercedes-Benz Group (ex Daimler) 710000 RWE 703712
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Großer Verfallstag: DAX vor weiterem Rückschlag -- Wenig Bewegung an den Börsen in Asien -- Shutdown-Gefahr in den USA -- Covestro fliegt aus dem DAX -- Nike übertrifft Erwartungen -- FedEx im Fokus
Top News
Commerzbank will Beratung in Filialen verbessern Commerzbank will Beratung in Filialen verbessern
FedEx-Aktie hebt ab: FedEx spaltet Frachtgeschäft ab FedEx-Aktie hebt ab: FedEx spaltet Frachtgeschäft ab
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
LAST MINUTE GESCHENK mit Herz und Verstand: Der FLEXINVEST JUNIOR-SPARPLAN. Hier KOSTENLOS abschließen & bis zu 75 € Amazon.de* Gutscheine erhalten!

Santander Aktie

NeuKaufenVerkaufen
Santander Aktien-Sparplan
4,40 EUR -0,12 EUR -2,67 %
STU
4,42 EUR -0,07 EUR -1,65 %
GVIE
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.68,47 Mrd. EUR

KGV5,77Div. Rendite3,77%

WKN858872

ISINES0113900J37

SymbolBCDRF

Santander Aktien News

DatumMeistgelesen
PR NewswireBeyfortus® immunization to protect infants from RSV has begun
PR NewswireBeyfortus® immunization to protect infants from RSV has begun
PR NewswireFLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals
Wer­bungSantander-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireFluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
PR NewswireFluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
PR NewswireSanofi ships U.S. influenza vaccines for the 2024/25 season
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banco Santander, S.A. - SAN
PR NewswireROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Banco Santander, S.A. Investors to Inquire About Securities Class Action Investigation - SAN
PR NewswireSAN INVESTOR NEWS: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Banco Santander, S.A. Investors to Inquire About Securities Class Action Investigation - SAN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banco Santander, S.A. - SAN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banco Santander, S.A. - SAN
PR NewswireBirchway Tropicana Aims to Bring High Quality Living at Value Pricing to Las Vegas
PR NewswireSanofi launches "The 1 Pledge" movement to drive early screening for type 1 diabetes in the U.S.
PR NewswireSanofi and rapper/actor Ice-T unveil trailer for The Season as a warning against the flu
PR NewswireSanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact
PR NewswireSanofi Breaks Ground on State-of-the-Art Facility in Swiftwater for Sustainable Production of Pandemic Flu Vaccines
PR NewswireBetty Jotanovic Is Named President of Chrysler Capital and Auto Relationships at Santander Consumer
PR NewswireSanofi launches first global scholarship program for students from underrepresented communities pursuing careers in healthcare
PR NewswirePositive Dupixent® (dupilumab) Phase 3 Results in Adults and Adolescents with Eosinophilic Esophagitis Published in the New England Journal of Medicine
PR NewswireDupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Eosinophilic Esophagitis
PR NewswireDupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Prurigo Nodularis
PR NewswireDupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Prurigo Nodularis
PR NewswireDupixent® (dupilumab) Late-Breaking Phase 3 Data Presented at UEG Week 2022 Showed Significant Histological Remission of Eosinophilic Esophagitis (EoE) in Children 1 to 11 Years Old
PR NewswireSanofi US enters into co-promotion agreement with Provention Bio, Inc. to launch teplizumab, an investigational disease-modifying therapy for type 1 diabetes
PR NewswireDupixent® (dupilumab) Approved by FDA as the First and Only Treatment Indicated for Prurigo Nodularis
MyDividendsSantander kauft eigene Aktien zurück und erhöht die Zwischendividende
PR NewswireLate-Breaking Dupixent® (dupilumab) Data at ERS 2022 Show Consistent Efficacy and Safety Profile for Up to Two Years in Children Aged 6 to 11 Years with Moderate-to-severe Asthma
PR NewswirePublic health experts underscore importance of flu vaccinations to help reduce health inequities among high-risk populations
PR NewswireSantander Bank Teams Up with Rocket Mortgage to Provide Clients with Digitally Driven Home Loan Experience
PR NewswireSanofi appoints new Heads of U.S. General Medicines, and North America Vaccines and Consumer Healthcare
PR NewswireSanofi partners with Howard University in an unprecedented pharmacy fellowship program
PR NewswireSanofi flu vaccines licensed and approved for 2022-2023 influenza season, including CDC preferred higher-dose vaccines for adults 65+
PR NewswireFDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis
PR NewswireSantander Consumer USA Brings Cultivate Small Business Program to Dallas in Partnership with Impact Ventures
PR NewswireSobi: FDA grants efanesoctocog alfa Breakthrough Therapy designation for haemophilia A
PR NewswireFDA Accepts Dupixent® (dupilumab) for Priority Review in Adults with Prurigo Nodularis
PR NewswireFDA Approves Dupixent® (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis
PR NewswireLate-breaking Phase 3 Data at AAD 2022 Show Dupixent® (dupilumab) Significantly Improved Signs and Symptoms of Prurigo Nodularis
PR NewswireLibtayo® (cemiplimab) now approved in Canada for the treatment of recurrent or metastatic cervical cancer
PR NewswireLibtayo® (cemiplimab) now approved in Canada for the treatment of recurrent or metastatic cervical cancer

Santander News

Santander News: auf dieser Seite finden Sie alle Santander News und Nachrichten zur Santander Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Santander News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Santander News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.